Effects of Octreotide on Morphology of Pituitary Adenomas in Acromegaly

ON THE BINDING OF CONGO RED BY AMYLOID

1962 • 1,128 citations

NOTE ON AN EXACT TREATMENT OF CONTINGENCY, GOODNESS OF FIT AND OTHER PROBLEMS OF SIGNIFICANCE

1951 • 826 citations

Preoperative Treatment of Acromegaly with Long-Acting Somatostatin Analog SMS 201-995: Shrinkage of Invasive Pituitary Macroadenomas and Improved Surgical Remission Rate*

1988 • 191 citations

Therapeutic Efficacy of the Somatostatin Analog SMS 201-995 (Octreotide) in Acromegaly

1990 • 133 citations

Treatment of Acromegaly with the Long-Acting Somatostatin Analog SMS 201-995*

1988 • 112 citations

EFFECT OF SMS 201–995, A LONG‐ACTING SOMATOSTATIN ANALOGUE, ON THE SECRETION AND MORPHOLOGY OF A PITUITARY GROWTH HORMONE CELL ADENOMA

1987 • 56 citations

Shrinking of a Growth Hormone-Producing Pituitary Tumor by Continuous Subcutaneous Infusion of the Somatostatin Analog SMS 201-995

1987 • 45 citations

Relationship between growth hormone and Somatomedin‐C levels in untreated acromegaly, after surgery and radiotherapy and during medical therapy with Sandostatin (SMS 201–995)

1987 • 40 citations

Response of a GH- and TSH-Secreting Pituitary Adenoma to a Somatostatin Analogue (SMS 201-995): Evidence that GH and TSH Coexist in the Same Cell and Secretory Granules

1989 • 32 citations

Effects of somatostatin on somatotroph adenomas of the human pituitary: An in vitro functional and morphological study

1990 • 16 citations

Effect of treatment with octreotide on the morphology of growth hormone—secreting pituitary adenomas: Study of 24 cases

1991 • 13 citations

Compassionate use of norfloxacin

1987 • 12 citations

The role of Sandostatin® in acromegaly

1992 • 12 citations

The somatostatin analogue SMS 201-995 in acromegaly: prolonged, preferential suppression of growth hormone but not pancreatic hormones.

1987 • 10 citations

Acromegaly

1987 • 7 citations

Single-dose response study of the somatostatin analogue octreotide in acromegaly

1989 • 4 citations